These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 29796012)

  • 1. Accounting for equity considerations in cost-effectiveness analysis: a systematic review of rotavirus vaccine in low- and middle-income countries.
    Boujaoude MA; Mirelman AJ; Dalziel K; Carvalho N
    Cost Eff Resour Alloc; 2018; 16():18. PubMed ID: 29796012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distributional cost-effectiveness analysis in low- and middle-income countries: illustrative example of rotavirus vaccination in Ethiopia.
    Dawkins BR; Mirelman AJ; Asaria M; Johansson KA; Cookson RA
    Health Policy Plan; 2018 Apr; 33(3):456-463. PubMed ID: 29309581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incorporating Equity Concerns in Cost-Effectiveness Analyses: A Systematic Literature Review.
    Ward T; Mujica-Mota RE; Spencer AE; Medina-Lara A
    Pharmacoeconomics; 2022 Jan; 40(1):45-64. PubMed ID: 34713423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Equity in Economic Evaluations of Early Childhood Development Interventions in Low-and Middle-Income Countries: Scoping Review.
    Baek Y; Ademi Z; Fisher J; Tran T; Owen A
    Matern Child Health J; 2023 Jun; 27(6):1009-1029. PubMed ID: 37036566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Public finance of rotavirus vaccination in India and Ethiopia: an extended cost-effectiveness analysis.
    Verguet S; Murphy S; Anderson B; Johansson KA; Glass R; Rheingans R
    Vaccine; 2013 Oct; 31(42):4902-10. PubMed ID: 23871824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global economic evaluations of rotavirus vaccines: A systematic review.
    Kotirum S; Vutipongsatorn N; Kongpakwattana K; Hutubessy R; Chaiyakunapruk N
    Vaccine; 2017 Jun; 35(26):3364-3386. PubMed ID: 28504193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic Review and Meta-Analysis of Cost-effectiveness of Rotavirus Vaccine in Low-Income and Lower-Middle-Income Countries.
    Haider S; Chaikledkaew U; Thavorncharoensap M; Youngkong S; Islam MA; Thakkinstian A
    Open Forum Infect Dis; 2019 Apr; 6(4):ofz117. PubMed ID: 31049363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Equity-Informative Economic Evaluations of Vaccines: A Systematic Literature Review.
    Patikorn C; Cho JY; Lambach P; Hutubessy R; Chaiyakunapruk N
    Vaccines (Basel); 2023 Mar; 11(3):. PubMed ID: 36992206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative evaluation of the potential impact of rotavirus versus HPV vaccination in GAVI-eligible countries: a preliminary analysis focused on the relative disease burden.
    Kim SY; Sweet S; Chang J; Goldie SJ
    BMC Infect Dis; 2011 Jun; 11():174. PubMed ID: 21679420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Examining Equity Effects of Health Interventions in Cost-Effectiveness Analysis: A Systematic Review.
    Avanceña ALV; Prosser LA
    Value Health; 2021 Jan; 24(1):136-143. PubMed ID: 33431148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical Analysis of Economic Evaluation of the Childhood Rotavirus Vaccination in Low- and Lower-Middle-Income Countries: A Systematic Review.
    Ray S; Pathak S; Kshtriya P
    Value Health Reg Issues; 2023 Nov; 38():18-28. PubMed ID: 37437462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using Cost-Effectiveness Analysis to Address Health Equity Concerns.
    Cookson R; Mirelman AJ; Griffin S; Asaria M; Dawkins B; Norheim OF; Verguet S; J Culyer A
    Value Health; 2017 Feb; 20(2):206-212. PubMed ID: 28237196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guidance on priority setting in health care (GPS-Health): the inclusion of equity criteria not captured by cost-effectiveness analysis.
    Norheim OF; Baltussen R; Johri M; Chisholm D; Nord E; Brock D; Carlsson P; Cookson R; Daniels N; Danis M; Fleurbaey M; Johansson KA; Kapiriri L; Littlejohns P; Mbeeli T; Rao KD; Edejer TT; Wikler D
    Cost Eff Resour Alloc; 2014; 12():18. PubMed ID: 25246855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of geographic and economic heterogeneity on rotavirus diarrhea burden and vaccination impact and cost-effectiveness in the Lao People's Democratic Republic.
    Rheingans R; Anderson JD; Bagamian KH; Pecenka CJ
    Vaccine; 2018 Dec; 36(51):7868-7877. PubMed ID: 30007827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of a new rotavirus vaccination program in Pakistan: a decision tree model.
    Patel HD; Roberts ET; Constenla DO
    Vaccine; 2013 Dec; 31(51):6072-8. PubMed ID: 24176497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distributional impact of rotavirus vaccination in 25 GAVI countries: estimating disparities in benefits and cost-effectiveness.
    Rheingans R; Atherly D; Anderson J
    Vaccine; 2012 Apr; 30 Suppl 1():A15-23. PubMed ID: 22520124
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.